Patents by Inventor Shingo Miyamoto
Shingo Miyamoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11916491Abstract: An electric power converter includes a plurality of power modules, a capacitor, a positive bus bar, and a negative bus bar. Each of the power modules includes a positive terminal and a negative terminal on a side facing the capacitor. Leading ends of the positive terminal and negative terminal are parallel to the side. The positive bus bar includes a positive/negative base plate joined to a positive/negative electrode of the capacitor and a positive/negative flange bent from the positive/negative base plate. The positive/negative flange is joined to the positive/negative terminals of the power modules. The positive flange and the negative flange extend in directions away from the capacitor.Type: GrantFiled: March 1, 2022Date of Patent: February 27, 2024Assignee: DENSO CORPORATIONInventors: Shingo Miyamoto, Yohei Imai
-
Publication number: 20230035343Abstract: Provided is a method for predicting the onset of chorioamnionitis, which may predict the onset of chorioamnionitis with high sensitivity. The method including obtaining a base sequence data group of a 16S ribosomal RNA gene in a sample from the vagina of a subject; detecting the presence of a bacterium selected from a bacterial group represented by G1 below based on the data group obtained; and associating the sample with the likelihood of onset of chorioamnionitis based on the number of bacterial species detected. The bacterial group G1: Finegoldia magna; Streptococcus anginosus; Aerococcus christensenii; Lactobacillus jensenii; Ureaplasma parvum; Prevotella disiens; Lactobacillus vaginalis; Prevotella buccalis; Dialister micraerophilus; Atopobium vaginae; Prevotella bivia; Prevotella amnii; Anaerococcus lactolytcus; Streptococcus agalactiae; Anaerococcus tetradius; Bacteroides fragilis; Gardnerella vaginalis; Mycoplasma hominis; and Sneathia sanguinegens.Type: ApplicationFiled: December 4, 2020Publication date: February 2, 2023Inventors: Shingo MIYAMOTO, Daichi URUSHIYAMA, Kenichiro HATA
-
Patent number: 11464762Abstract: A carcinogenesis inhibitor having no side effect and having an excellent effect by oral administration. A carcinogenesis inhibitor containing a hydantoin derivative or a pharmaceutically acceptable salt thereof as an active ingredient shows an inhibiting action for polyp formation and for cell proliferation, and has no side effect and highly safe whereby it is very highly useful as a pharmaceutical agent and a food such as supplement which prevent the occurrence and progress of cancer, inhibits the recurrence and metastasis of cancer and further achieves the therapeutic effect.Type: GrantFiled: June 12, 2018Date of Patent: October 11, 2022Assignees: NATIONAL CANCER CENTER, NIPPON ZOKI PHARMACEUTICAL CO., LTD.Inventors: Michihiro Mutoh, Yurie Kurokawa, Gen Fujii, Shingo Miyamoto
-
Publication number: 20220288132Abstract: Provided a method for preparing a blastocyst. The method includes culturing a fertilized egg in a culture medium containing bubbles containing a reducing gas. The reducing gas may contain at least one selected from the group consisting of hydrogen, carbon monoxide, nitrogen monoxide, and hydrogen sulfide. The bubbles may have an average particle size of from 10 nm to 1,000 nm.Type: ApplicationFiled: March 9, 2022Publication date: September 15, 2022Inventor: Shingo Miyamoto
-
Publication number: 20220190737Abstract: An electric power converter includes a plurality of power modules, a capacitor, a positive bus bar, and a negative bus bar. Each of the power modules includes a positive terminal and a negative terminal on a side facing the capacitor. Leading ends of the positive terminal and negative terminal are parallel to the side. The positive bus bar includes a positive/negative base plate joined to a positive/negative electrode of the capacitor and a positive/negative flange bent from the positive/negative base plate. The positive/negative flange is joined to the positive/negative terminals of the power modules. The positive flange and the negative flange extend in directions away from the capacitor.Type: ApplicationFiled: March 1, 2022Publication date: June 16, 2022Applicant: DENSO CORPORATIONInventors: Shingo MIYAMOTO, Yohei IMAI
-
Publication number: 20220081675Abstract: Provided a method for preparing a blastocyst from a fertilized egg. The method for preparing a blastocyst includes a culture of a fertilized egg in a mixed culture medium containing a culture medium for stem cells and a culture medium for a fertilized egg, wherein the culture of a fertilized egg is performed together with a culture of adipose tissue-derived stem cells apart from the fertilized egg.Type: ApplicationFiled: September 15, 2021Publication date: March 17, 2022Inventors: Shingo MIYAMOTO, Fumitoshi KOGA, Fusanori YOTSUMOTO, Toyofumi HIRAKAWA
-
Publication number: 20200350643Abstract: A lithium ion battery comprises a positive electrode terminal and a negative electrode terminal, a battery case, and an electrode body housed inside the battery case. The electrode body has a positive electrode current collector and a positive-electrode electrode plate and a negative electrode current collector and a negative-electrode electrode plate, and has a structure in which the positive-electrode electrode plate and the negative-electrode electrode plate are laminated via a separator. A carbon-based porous material in a battery case has a methane gas absorption capacity and preferably has a carbon dioxide gas absorption capacity and has a pore volume of 0.3 mL/g or less, for pores having a pore size of 4.5 ? or more. Such a gas absorber for a lithium ion battery generates no gas from reaction with an electrolytic solution of the lithium ion battery and can suitably absorb methane gas generated at the time of abnormality.Type: ApplicationFiled: March 29, 2018Publication date: November 5, 2020Inventors: Jun KANEKO, Shingo MIYAMOTO, Mitsuru NOZUE
-
Publication number: 20200281261Abstract: A smoking article includes an aerosol generating rod, and a filter portion disposed adjacent to the aerosol generating rod. The filter portion includes a filter body, a capsule member, and an adhesive. The capsule member contains a flavorant inside and is embedded in the filter body. The adhesive bonds the filter body and the capsule member.Type: ApplicationFiled: May 26, 2020Publication date: September 10, 2020Applicant: Japan Tobacco Inc.Inventors: Yuji Yamauchi, Takashi Omura, Shingo Miyamoto
-
Publication number: 20200276163Abstract: A carcinogenesis inhibitor having no side effect and having an excellent effect by oral administration. A carcinogenesis inhibitor containing a hydantoin derivative or a pharmaceutically acceptable salt thereof as an active ingredient shows an inhibiting action for polyp formation and for cell proliferation, and has no side effect and highly safe whereby it is very highly useful as a pharmaceutical agent and a food such as supplement which prevent the occurrence and progress of cancer, inhibits the recurrence and metastasis of cancer and further achieves the therapeutic effect.Type: ApplicationFiled: June 12, 2018Publication date: September 3, 2020Applicants: NATIONAL CANCER CENTER, NIPPON ZOKI PHARMACEUTICAL CO., LTD.Inventors: Michihiro MUTOH, Yurie KUROKAWA, Gen FUJII, Shingo MIYAMOTO
-
Publication number: 20200118726Abstract: A reactor may include: a ring core having a ring shape; a resin cover covering the ring core with a space left on an inner side relative to the ring core; and a columnar core around which a winding is wound. The columnar core may be fixed to the resin cover in a state where each of ends of the columnar core is opposed to an inner surface of the ring core.Type: ApplicationFiled: September 4, 2019Publication date: April 16, 2020Applicant: TOYOTA JIDOSHA KABUSHIKI KAISHAInventor: Shingo MIYAMOTO
-
Publication number: 20200078409Abstract: A pharmaceutical composition contains adipose tissue derived reproductive cells including adipose stem cells, vascular endothelial cells and vascular pericytes. The composition is administrated into an intrauterine cavity of a subject and used for treatment of infertility. A method for producing the pharmaceutical composition includes treating an adipose tissue with a disaggregation agent to obtain a disaggregated tissue; concentrating reproductive cells from the disaggregated tissue by centrifugal separation treatment; and recovering concentrated reproductive cells. A method for treatment of infertility of a subject includes administering a pharmaceutical composition into an intrauterine cavity of a subject. The pharmaceutical composition contains adipose tissue derived reproductive cells including adipose stem cells, vascular endothelial cells and vascular pericytes.Type: ApplicationFiled: November 14, 2019Publication date: March 12, 2020Applicant: FUKUOKA UNIVERSITYInventors: Shingo MIYAMOTO, Fusanori YOTSUMOTO
-
Patent number: 10486623Abstract: A harness routing structure for an electric vehicle includes a battery, an inverter device, and a harness configured to connect the battery and the inverter device. A length L of the harness between a battery fixing end of the battery to which the harness is fixed and an inverter fixing end of the inverter device to which the harness is fixed is an integer multiple of a parameter ?a associated with a rising wavelength ? when the inverter device is driven, and the parameter ?a satisfies 0.462???a?0.538?.Type: GrantFiled: September 17, 2018Date of Patent: November 26, 2019Assignee: HONDA MOTOR CO., LTD.Inventors: Satoshi Hashino, Toshikatsu Mori, Hiroki Nakatani, Shingo Miyamoto
-
Patent number: 10278070Abstract: Power usage of each of one or more devices belonging to a group is collected at prescribed intervals, and an authentication request including group identification information for identification of the group to be authenticated is received from a terminal. Upon receipt of the authentication request, a device as a manipulation target in the group and details of a manipulation on the device are determined, and notification is provided to the terminal. Whether the device designated by the notification is manipulated is judged on the basis of a change in the power usage of each of the devices belonging to the group. If the device designated by the notification is judged to be manipulated, authentication information is transmitted to the terminal.Type: GrantFiled: October 12, 2016Date of Patent: April 30, 2019Assignee: PANASONIC INTELLECTUAL PROPERTY MANAGEMENT CO., LTD.Inventors: Shingo Miyamoto, Hayashi Ito, Kumi Harada
-
Publication number: 20190084504Abstract: A harness routing structure for an electric vehicle includes a battery, an inverter device, and a harness configured to connect the battery and the inverter device. A length L of the harness between a battery fixing end of the battery to which the harness is fixed and an inverter fixing end of the inverter device to which the harness is fixed is an integer multiple of a parameter ?a associated with a rising wavelength ? when the inverter device is driven, and the parameter ?a satisfies 0.462???a?0.538?.Type: ApplicationFiled: September 17, 2018Publication date: March 21, 2019Inventors: Satoshi Hashino, Toshikatsu Mori, Hiroki Nakatani, Shingo Miyamoto
-
Publication number: 20180296604Abstract: A pharmaceutical composition contains adipose tissue derived reproductive cells including adipose stem cells, vascular endothelial cells and vascular pericytes. The composition is administrated into an intrauterine cavity of a subject and used for treatment of infertility. A method for producing the pharmaceutical composition includes treating an adipose tissue with a disaggregation agent to obtain a disaggregated tissue; concentrating reproductive cells from the disaggregated tissue by centrifugal separation treatment; and recovering concentrated reproductive cells. A method for treatment of infertility of a subject includes administering a pharmaceutical composition into an intrauterine cavity of a subject. The pharmaceutical composition contains adipose tissue derived reproductive cells including adipose stem cells, vascular endothelial cells and vascular pericytes.Type: ApplicationFiled: November 21, 2017Publication date: October 18, 2018Inventors: Shingo MIYAMOTO, Fusanori YOTSUMOTO
-
Patent number: 10083769Abstract: In an electrodeposition treatment of an iron-group metal ion-containing liquid, without being influenced by the properties of the iron-group metal ion-containing liquid, iron-group metal ions are efficiently removed from the liquid by precipitation. An anode chamber 2A provided with an anode 2 and a cathode chamber 3A provided with a cathode 3 are separated from each other by a cation exchange membrane 5, an iron-group metal ion-containing liquid is charged into the anode chamber 2A, a cathode liquid is charged into the cathode chamber 3A, and by applying the voltage between the anode 2 and the cathode 3, iron-group metal ions in the liquid in the anode chamber 2A are moved into the liquid in the cathode chamber 3A through the cation exchange membrane 5, so that an iron-group metal is precipitated on the cathode 3.Type: GrantFiled: October 20, 2014Date of Patent: September 25, 2018Assignees: KURITA WATER INDUSTRIES LTD., HITACHI-GE NUCLEAR ENERGY, LTD.Inventors: Shingo Miyamoto, Mamoru Iwasaki, Mami Hirose, Motohiro Aizawa, Nobuyuki Ota, Takako Sumiya, Kazushige Ishida
-
Patent number: 9977823Abstract: A content control method according to the present disclosure includes: obtaining first content file information including attribute information items each on one of first content files which belong to a first content file group; obtaining second content file information including attribute information items each on one of second content files which belong to a second content file group; narrowing down the first content files, the narrowed-down first content files each having an attribute information item satisfying a condition which is set based on the first content file information and the second content file information; and identifying a first content file and a second content file which are partially or entirely same by matching entity information items each on one of the second content files and entity information items each on one or more of the narrowed-down first content files as matching targets.Type: GrantFiled: July 3, 2013Date of Patent: May 22, 2018Assignee: PANASONIC INTELLECTUAL PROPERTY CORPORATION OF AMERICAInventors: Keiji Icho, Ryouichi Kawanishi, Shingo Miyamoto, Kento Ogawa
-
Publication number: 20180079663Abstract: A method in which an anode chamber and a cathode chamber are separated by a cation exchange membrane, an acid solution containing metal ions is introduced into the anode chamber, a cathode solution is introduced into the cathode chamber, and a current is applied across the anode and the cathode, whereby the metal ions in the solution in the anode chamber pass through the cation exchange membrane, move into the cathode solution, and precipitate as metal onto the cathode, wherein there are minimal instances where electrodeposition is impossible or the electrodeposition rate decreases. Pre-adding a salt of the acid contained in the acid solution makes it possible to suppress concentration-diffusion of the acid from the acid solution. Adding a salt of the acid into the cathode chamber makes it possible to reduce the impressed voltage, reduce the amount of hydrogen generated on the cathode, and reduce the amount of power.Type: ApplicationFiled: March 30, 2016Publication date: March 22, 2018Inventors: Shingo MIYAMOTO, Mami HIROSE, Mamoru IWASAKI, Hideyuki KOMORI, Motohiro AIZAWA, Nobuyuki OTA, Takako SUMIYA, Kazushige ISHIDA
-
Patent number: 9641501Abstract: A content sharing system includes: a server; a first information communication apparatus; and a second information communication apparatus, in which the first information communication apparatus includes a reserve requesting unit which sends to the server a reserve request message for requesting to reserve a sharing space to be newly generated, the reserve request message including first identification information for identifying the second information communication apparatus or the user using the second information communication apparatus, and the server includes: a first storage; and a sharing space generating unit which, upon receiving the reserve request message, generates the sharing space in the first storage, and stores in the first storage the first identification information included in the reserve request message.Type: GrantFiled: December 6, 2013Date of Patent: May 2, 2017Assignee: PANASONIC INTELLECTUAL PROPERTY CORPORATION OF AMERICAInventors: Shingo Miyamoto, Keiji Icho, Kento Ogawa
-
Publication number: 20170034701Abstract: Power usage of each of one or more devices belonging to a group is collected at prescribed intervals, and an authentication request including group identification information for identification of the group to be authenticated is received from a terminal. Upon receipt of the authentication request, a device as a manipulation target in the group and details of a manipulation on the device are determined, and notification is provided to the terminal. Whether the device designated by the notification is manipulated is judged on the basis of a change in the power usage of each of the devices belonging to the group. If the device designated by the notification is judged to be manipulated, authentication information is transmitted to the terminal.Type: ApplicationFiled: October 12, 2016Publication date: February 2, 2017Inventors: SHINGO MIYAMOTO, HAYASHI ITO, KUMI HARADA